Patents by Inventor James Robert Hartnett

James Robert Hartnett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9469857
    Abstract: The invention provides vectors and methods for directional cloning.
    Type: Grant
    Filed: October 17, 2011
    Date of Patent: October 18, 2016
    Assignee: PROMEGA CORPORATION
    Inventors: Michael R. Slater, James Robert Hartnett
  • Patent number: 9371531
    Abstract: The invention provides vectors and methods for directional cloning.
    Type: Grant
    Filed: January 14, 2013
    Date of Patent: June 21, 2016
    Assignee: PROMEGA CORPORATION
    Inventors: Michael R. Slater, Ethan Edward Strauss, Keith V. Wood, James Robert Hartnett
  • Patent number: 9018014
    Abstract: The invention provides vectors and methods for directional cloning.
    Type: Grant
    Filed: October 17, 2011
    Date of Patent: April 28, 2015
    Assignee: Promega Corporation
    Inventors: Michael R. Slater, Keith V. Wood, James Robert Hartnett
  • Publication number: 20140186959
    Abstract: The invention provides vectors and methods for directional cloning.
    Type: Application
    Filed: October 17, 2011
    Publication date: July 3, 2014
    Applicant: PROMEGA CORPORATION
    Inventors: Michael R. Slater, Keith V. Wood, James Robert Hartnett
  • Publication number: 20130183760
    Abstract: The invention provides vectors and methods for directional cloning.
    Type: Application
    Filed: October 17, 2011
    Publication date: July 18, 2013
    Applicant: PROMEGA CORPORATION
    Inventors: Michael R. Slater, Keith V. Wood, James Robert Hartnett
  • Patent number: 8367403
    Abstract: The invention provides vectors and methods for directional cloning.
    Type: Grant
    Filed: December 28, 2009
    Date of Patent: February 5, 2013
    Assignee: Promega Corporation
    Inventors: Michael R. Slater, Ethan Edward Strauss, Keith V. Wood, James Robert Hartnett
  • Patent number: 8293503
    Abstract: The invention provides vectors and methods for directional cloning.
    Type: Grant
    Filed: October 3, 2003
    Date of Patent: October 23, 2012
    Assignee: Promega Corporation
    Inventors: Michael R. Slater, Ethan Edward Strauss, Keith V. Wood, James Robert Hartnett
  • Publication number: 20100216231
    Abstract: The invention provides vectors and methods for directional cloning.
    Type: Application
    Filed: December 28, 2009
    Publication date: August 26, 2010
    Inventors: Michael R. Slater, Ethan Edward Strauss, Keith V. Wood, James Robert Hartnett
  • Publication number: 20090137020
    Abstract: The present invention relates to reverse transcription of RNA, and in particular to reverse transcription by thermostable DNA polymerases. Thermoactinomyces vulgaris and Bacillus stearothermophilus possess reverse transcriptase activity in the presence of magnesium or manganese ions. Methods, compositions, and kits for reverse transcription and RT-PCR are also provided.
    Type: Application
    Filed: January 20, 2009
    Publication date: May 28, 2009
    Applicant: PROMEGA CORPORATION
    Inventors: Trent Gu, Fen Huang, James Robert Hartnett
  • Patent number: 7504220
    Abstract: The present invention relates to reverse transcription of RNA, and in particular to reverse transcription by thermostable DNA polymerases. Thermoactinomyces vulgaris and Bacillus stearothermophilus possess reverse transcriptase activity in the presence of magnesium or manganese ions. Methods, compositions, and kits for reverse transcription and RT-PCR are also provided.
    Type: Grant
    Filed: June 27, 2006
    Date of Patent: March 17, 2009
    Assignee: Promega Corporation
    Inventors: Trent Gu, Fen Huang, James Robert Hartnett
  • Patent number: 7214522
    Abstract: The present invention provides compositions comprising thermostable DNA polymerases derived from hyperthermophilic eubacteria. In particular, the present invention comprises thermostable DNA polymerases from the hyperthermophilic eubacterial species Thermoactinomyces vulgaris. The present invention also provides methods for utilizing naturally-occurring and non-naturally-occurring forms of T. vulgaris DNA polymerase in sequencing, reverse transcription, and amplification reactions.
    Type: Grant
    Filed: May 23, 2003
    Date of Patent: May 8, 2007
    Assignee: Promega Corporation
    Inventors: Trent Gu, Fen Huang, James Robert Hartnett
  • Patent number: 7094539
    Abstract: The present invention relates to reverse transcription of RNA, and in particular to reverse transcription by thermostable DNA polymerases. Thermoactinomyces vulgaris and Bacillus stearothermophilus possess reverse transcriptase activity in the presence of magnesium or manganese ions. Methods, compositions, and kits for reverse transcription and RT-PCR are also provided.
    Type: Grant
    Filed: June 24, 2002
    Date of Patent: August 22, 2006
    Assignee: Promega Corporation
    Inventors: Trent Gu, Fen Huang, James Robert Hartnett
  • Patent number: 6730479
    Abstract: Processes are disclosed using the depolymerization of a nucleic acid hybrid to qualitatively and quantitatively analyze for the presence of a predetermined nucleic acid. Applications of those processes include the detection of single nucleotide polymorphisms, identification of single base changes, speciation, determination of viral load, genotyping, medical marker diagnostics, and the like.
    Type: Grant
    Filed: February 22, 2001
    Date of Patent: May 4, 2004
    Assignee: Promega Corporation
    Inventors: John William Shultz, Martin K. Lewis, Donna Leippe, Michelle Mandrekar, Daniel Kephart, Richard Byron Rhodes, Christine Ann Andrews, James Robert Hartnett, Trent Gu, Ryan J. Olson, Keith V. Wood, Roy Welch
  • Patent number: 6653078
    Abstract: Processes are disclosed using the depolymerization of a nucleic acid hybrid to qualitatively and quantitatively analyze for the presence of predetermined nucleic acid target sequences using a multiplex assay format. Applications of those processes include the detection of single nucleotide polymorphisms, identification of single base changes, speciation, genotyping, medical marker diagnostics, and the like.
    Type: Grant
    Filed: February 20, 2001
    Date of Patent: November 25, 2003
    Assignee: Promega Corporation
    Inventors: Martin K. Lewis, Daniel Kephart, Richard Byron Rhodes, John William Shultz, Donna Leippe, Michelle Mandrekar, Christine Ann Andrews, James Robert Hartnett, Trent Gu, Keith V. Wood, Roy Welch
  • Publication number: 20030203358
    Abstract: Processes are disclosed using the depolymerization of a nucleic acid hybrid to qualitatively and quantitatively analyze for the presence of a predetermined exogenous nucleic acid. Applications of those processes include the detection of single nucleotide polymorphisms, identification of single base changes, determination of viral load, genotyping, medical marker diagnostics, and the like.
    Type: Application
    Filed: February 9, 2001
    Publication date: October 30, 2003
    Applicant: Promega Corporation
    Inventors: John William Shultz, Martin K. Lewis, Donna Leippe, Michelle Mandrekar, Daniel Kephart, Richard Byron Rhodes, Christine Ann Andrews, James Robert Hartnett, Trent Gu, Ryan J. Olson, Keith V. Wood, Roy Welch
  • Publication number: 20030194699
    Abstract: Processes are disclosed using the depolymerization of a nucleic acid hybrid to qualitatively and quantitatively analyze for the presence of predetermined nucleic acid target sequences using a multiplex assay format. Applications of those processes include the detection of single nucleotide polymorphisms, identification of single base changes, speciation, genotyping, medical marker diagnostics, and the like.
    Type: Application
    Filed: February 20, 2001
    Publication date: October 16, 2003
    Applicant: Promega Corporation
    Inventors: Martin K. Lewis, Daniel Kephart, Richard Byron Rhodes, John William Shultz, Donna Leippe, Michelle Mandrekar, Christine Ann Andrews, James Robert Hartnett, Trent Gu, Keith V. Wood, Roy Welch
  • Patent number: 6632645
    Abstract: The present invention provides compositions comprising thermostable DNA polymerases derived from hyperthermophilic eubacteria. In particular, the present invention comprises thermostable DNA polymerases from the hyperthermophilic eubacterial species Thermoactinomyces vulgaris. The present invention also provides methods for utilizing naturally-occurring and non-naturally-occurring forms of T. vulgaris DNA polymerase in sequencing, reverse transcription, and amplification reactions.
    Type: Grant
    Filed: March 2, 2000
    Date of Patent: October 14, 2003
    Assignee: Promega Corporation
    Inventors: Trent Gu, Fen Huang, James Robert Hartnett
  • Publication number: 20030180737
    Abstract: The present invention relates to reverse transcription of RNA, and in particular to reverse transcription by thermostable DNA polymerases. Thermoactinoinyces vulgaris and Bacillus stearothermophilus possess reverse transcriptase activity in the presence of magnesium or manganese ions. Methods, compositions, and kits for reverse transcription and RT-PCR are also provided.
    Type: Application
    Filed: June 24, 2002
    Publication date: September 25, 2003
    Inventors: Trent Gu, Fen Huang, James Robert Hartnett
  • Publication number: 20030077621
    Abstract: Processes are disclosed using the depolymerization of a nucleic acid hybrid to qualitatively and quantitatively analyze for the presence of a predetermined endogenous nucleic acid. Applications of those processes include the detection of single nucleotide polymorphisms, identification of single base changes, spieciation, determination of viral load, genotyping, medical marker diagnostics, and the like.
    Type: Application
    Filed: May 20, 2002
    Publication date: April 24, 2003
    Applicant: Promega Corporation
    Inventors: John William Shultz, Martin K. Lewis, Donna Leippe, Michelle Mandrekar, Daniel Kephart, Richard Byron Rhodes, Christine Ann Andrews, James Robert Hartnett, Trent Gu, Ryan J. Olson, Keith V. Wood, Roy Welch
  • Patent number: 6436677
    Abstract: The present invention relates to reverse transcription of RNA, and in particular to reverse transcription by thermostable DNA polymerases. Thermoactinomyces vulgaris and Bacillus stearothermophilus possess reverse transcriptase activity in the presence of magnesium or manganese ions. Methods, compositions, and kits for reverse transcription and RT-PCR are also provided.
    Type: Grant
    Filed: March 2, 2000
    Date of Patent: August 20, 2002
    Assignee: Promega Corporation
    Inventors: Trent Gu, Fen Huang, James Robert Hartnett